Robert Frist, Jr.
Analyst · Craig-Hallum Capital. You may begin
Thank you, Mollie. Good morning, and welcome to our first quarter 2020 earnings conference call. Normally the team and I will be speaking to you from a conference room in our headquarters. Instead we’re out and about in our homes and calling you from remote places. I hope that call facilitates well. In the COVID, the COVID pandemic has changed a great deal since our last earnings call which is only 10 weeks ago. Since that time over 56,000 people in the US have died due to COVID-19 and the number continues to grow. If this trend holds, the US will soon reach over 1 million documented cases of COVID-19, many of which are healthcare workers themselves. As of April 14th the CBC said that between 10% and 20% of all US coronavirus cases are among healthcare professionals. At HealthStream, we’ve ever been more resolute in our mission to support US healthcare workforce, the heroes who are literally putting their lives at risk to provide care to others. I want to start this call by acknowledging sincerely thanking the healthcare workers the world over for their attention to our needs and their selfless giving to take care of us all. Thank you. The impact of COVID-19 has been widespread rapidly evolving and generally characterized by uncertainty. In an attempt to contain the spread of COVID-19, authorities have implemented measures that have resulted in quarantines, travel bans and restrictions, shelter in place orders, the promotion of social distancing and limitations on business activity among other actions. These measures and then pandemic have caused a significant economic downturn in US and globally. Directly relevant to our business is the adverse impact the pandemic is having and will continue -- likely continue to have on the healthcare industry. Our business is focused on providing workforce and providing solutions to healthcare organizations along the continual care such that an adverse impact on healthcare organizations is likely to result in an adverse impact on our company. Though COVID-19 did not have a significant impact on our first quarter financial results based on what we are now seeing, the COVID-19 pandemic will begin to negatively impact our financial results in the second quarter of 2020. The extent, timing and duration of such impacts on our business remain uncertain and will depend on other things, the length and severity of the COVID-19 pandemic, especially with respect to its impact on healthcare organizations. Anyone watching the news knows that health organizations are being adversely affected on a number of levels; clinically, financially and operationally. Significant source of revenue from services such as elective surgeries have ground to a near halt due to restrictive measures including quarantine and shelter-in-place orders. At the same time, the cost of providing emergency care to COVID-19 patients has sharply increased. Unfortunately, it is unknown how long these conditions will persist or whether they will deteriorate. A week ago today on April 21st, Becker's Healthcare reported that 39 hospitals had just received negative S&P rating, noting that they each had about 100 days cash on hand or less. No healthcare provider seems exempt, as evidenced by few examples of challenges reported by some of our larger customers. For example, Quorum Health HealthStream customer, which operates 23 hospitals in 13 states announced on April 7th that it has filed Chapter 11 bankruptcy protection. Its quarterly earnings release on April 21st citing the uncertainties associated with COVID-19 HCA another HealthStream customer announced that it will suspend its quarterly dividend program and was withdrawing its previously issued guidance for 2020. On the same day, Southwell, Michigan based Beaumont Health, another HealthStream customer, which had 380,000 employees announced that it will temporarily lay off 2,400 employees and permanently eliminate about 450 positions and cut executive pay due to financial effects from the Coronavirus. Similar stories have been reported across many of our customers. And lot of these adverse developments experienced by these organizations, we are continuing to monitor the ability and willingness of our customers to pay for our solutions in a timely manner, implement solutions they have purchased from us and renew existing or purchase new products or services from us. We monitor our cash position and credit exposure primarily measuring weekly cash receipts, customer request to modify payment or contract terms, and bankruptcy notices. Since March, each of these areas has begun to show signs of slowing or deferral that we're unable to quantify the future impacts of such negative indicators, or know whether and to what extent they may increase over time. Any further deterioration in the flexibility of our accounts receivable or the timing of payments for customers will adversely impact our financial results. In fact, customers are currently making requests for extensions of time to pay their bills without incurring penalties. And we are working with each one of these customers to assess their need and provide them with such as much flexibility as we reasonably can. The timing of implementation is also relevant to our business, because our software solutions did not result in revenue recognition or billings until they are implemented. To the extent our customers delay or fail to implant products they have previously purchased, our financial results will be adversely impacted. While customer implementation projects are continuing, several customers have delayed starts or have put implementation projects on hold that were already in progress, making it difficult to project a number of implementation delays that we will ultimately receive. For example, two large implementations of the Red Cross Resuscitation Suite program have been impacted. One has been put on hold and the second has been partially delayed. In terms of sales and renewals, both continue but at a slower pace and with uncertainty as to when customers and prospects will broadly return to pre-COVID-19 levels of buying decisions. This should come as no surprise given what our customers are dealing with during this time. In fact, many customers are not allowing sales representatives on site until COVID-19 can be better controlled. Our sales representatives, account managers remain active, in a dialogue with our customers, but their primary focus over the past several weeks has shifted more towards maintaining relationships and providing support where we can. While we've been able to close deals across our solution sales teams, we are experiencing purchasing decisions being put on hold temporarily or deferred to later in the year. Given the uncertainty surrounding the adverse impact that COVID-19 is having on the healthcare industry and our business, we have taken certain expense management measures. These include indefinitely postponing and potentially foregoing increases to base salaries including executive base salaries, limiting hiring to critical positions, limiting the 401(k) match -- the company’s 401(k) match. And we've been negotiating with key vendors of ours to allow payment term extensions without penalty. We're continuing to monitor developments regarding the COVID-19 pandemic and may undertake further expense management initiatives if we deem necessary. Despite COVID-19 business does continue. So, I want to provide updates with regard to the three business transitions that we introduced and discussed in previous calls. All three transitions are designed to move us toward being a higher margin, more profitable company in the coming years, even though the impact of the pandemic is likely to extend these transitions longer than we had previously thought. First, we have transitioned our sales and marketing efforts from the legacy of resuscitation products to our new resuscitation offering. As a reminder, the new Red Cross Resuscitation Suite program is comprised of BLS, ALS and PALS competency-development curricula and we launched it in January of 2019. It brings an updated, highly adaptive competency-based development solution to healthcare professionals. It offers certification to healthcare professionals successfully demonstrating proficiency of lifesaving resuscitation knowledge and skills. We now in our last conference call for the full year 2019, we had signed over $38.8 million in contract order value for HealthStream’s new resuscitation offerings. These new contracts are from a mix of over 3,000 of our hospitals and healthcare facilities, and they’re from across the continued care including new and transitioning customers. While our customers focus has necessarily shifted in the last several weeks to respond to developments related to COVID-19 and treated -- treating COVID-19 patients, we have continued to see some new sales. Some -- given some customers preference to proceed with training implementation, our team created an innovative studio where virtual instruction could be provided. Customers’ feedback on our ability to accommodate their preference to stay on schedule using virtual training as a component of their implementation has done a positive development. In February, we announced the expansion of resuscitation offerings with Stable program, a leading neonatal education solution. This highly respected program is now available online, exclusively through HealthStream. We're encouraged to see buying activity – activities and surrounding activities. In fact, we hosted a webinar on April 7, and that over 813 attendees show up and 3,384 follow-up requests for information. We've already closed a handful of contracts shortly after the webinar. The addition of the Stable program further diversifies our product portfolio of simulation offerings. Second transition involves the adoption of migration of our new VerityStream platform. In the first quarter of 2018, we announced the launch of VerityStream, our new platform for managing credentialing and privileging in healthcare organizations. During the first quarter of 2020, over 20 new customer accounts were contracted for the VerityStream platform, bringing -- bringing our cumulative total to over 220. These 220 customers represent a mix of new customers and existing customers who chose to migrate from our legacy credentialing and privileging platforms to the new VerityStream platform. Sales of the VerityStream platform were exceptionally strong during the second half of 2019, but below our expectation for the first quarter. Additionally, the sales success realized in last half of 2019 created an implementation backlog resulting result in longer implementation cycles for our customers, and time to revenue for VerityStream, to address the backlog and accelerate the implementation cycle we have hired additional staff. These two factor lower new sales and slower implementation even without factoring impacted COVID-19 will likely result in lower revenues in operating income than we anticipated for the Provider Solutions segment for this year. The third transition involves our customers upgrading to the HealthStream platform which is the essential technology working behind the scenes that powers all activity and helping ecosystem. In the first quarter, we added approximately 240,000 HealthStream subscriptions bringing our cumulative total to approximately 3.4 million subscriptions which is up from 3.15 million contracted subscriptions at the end of the fourth quarter of 2019 and up 85% since the first quarter 2019. Undermine everyone that these three business transitions all represent multi-year journeys; in fact from my perspective last quarter I said that we were about 12 months into a 36 month journey. Given the unknown associated with COVID-19 especially its duration, it’s hard to predict with certainty, how much time will be added to the journey. But at 15 months end, I can say we continue to make real progress on all three transitions. At the end of these journeys, we still expect a higher margin, more profitable company. We are fortunate to have entered the pandemic with a solid balance sheet, no debt and a $50 million credit facility that remains fully available to us. Rather than being in a liquidity crisis, we believe that we are well-positioned to continue allocating capital to invest in the future of company. For the time being, that means keeping our share repurchase authorization in place and maintaining capital investment in new and existing product development. Should circumstances deteriorate, we are prepared to curtail or discontinue one or both of these initiatives but do not believe it is in the best interest of shareholders or the company to do so at this time. At this time Scottie Roberts will provide more detail discussion of the financial metrics for first quarter results, along further comments with how we view our financial outlook for 2020 given the COVID-19 pandemic. Scottie?